Jaguar Health develops plant-based, non-opioid medications for treating GI distress and debilitating diarrhea, according to a Jan. 30 news release from Jaguar.
Dr. Mulberg has 30 years of experience in pediatric gastroenterology, currently serving as an adjunct professor of pediatrics at the University of Maryland Medical Center in Baltimore.
Previously, he worked for the FDA and biopharmaceutical companies including Amicus Therapeutics, Neurogene and Johnson & Johnson, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.